These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 6151206)

  • 21. Deramciclane in the treatment of generalized anxiety disorder: a placebo-controlled, double-blind, dose-finding study.
    Naukkarinen H; Raassina R; Penttinen J; Ahokas A; Jokinen R; Koponen H; Lepola U; Kanerva H; Lehtonen L; Pohjalainen T; Partanen A; Mäki-Ikola O; Rouru J;
    Eur Neuropsychopharmacol; 2005 Dec; 15(6):617-23. PubMed ID: 15949921
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prazepam in anxiety: a controlled clinical trial [proceedings].
    Rickels K; Downing RW
    Psychopharmacol Bull; 1977 Apr; 13(2):19-21. PubMed ID: 323905
    [No Abstract]   [Full Text] [Related]  

  • 23. [Effect on vigilance of a single administration of clobazam].
    Mikus P
    Arzneimittelforschung; 1982; 32(11):1496-501. PubMed ID: 6129858
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Efficacy of kava-kava in the treatment of non-psychotic anxiety, following pretreatment with benzodiazepines.
    Malsch U; Kieser M
    Psychopharmacology (Berl); 2001 Sep; 157(3):277-83. PubMed ID: 11605083
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Insomnia in generalized anxiety disorder: polysomnographic, psychometric and clinical investigations before, during and after therapy with a long- versus a short-half-life benzodiazepine (quazepam versus triazolam).
    Saletu B; Anderer P; Brandstätter N; Frey R; Grünberger J; Klösch G; Mandl M; Wetter T; Zeitlhofer J
    Neuropsychobiology; 1994; 29(2):69-90. PubMed ID: 8170529
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Double-blind, placebo-controlled trial of two doses of abecarnil for geriatric anxiety.
    Small GW; Bystritsky A
    J Clin Psychiatry; 1997; 58 Suppl 11():24-9. PubMed ID: 9363045
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prazepam in anxiety: a controlled clinical trial.
    Rickels K; Sablosky L; Silverman H; Case WG; Rial W; Mirman M; Gottlieb S
    Compr Psychiatry; 1977; 18(3):239-49. PubMed ID: 858240
    [No Abstract]   [Full Text] [Related]  

  • 28. Initial study of methylclonazepam in generalized anxiety disorder. Evidence for greater power in the cross-over design.
    Ansseau M; Doumont A; Thiry D; von Frenckell R; Collard J
    Psychopharmacology (Berl); 1985; 87(2):130-5. PubMed ID: 3931136
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Naltrexone plus benzodiazepine aids abstinence in opioid-dependent patients.
    Stella L; D'Ambra C; Mazzeo F; Capuano A; Del Franco F; Avolio A; Ambrosino F
    Life Sci; 2005 Oct; 77(21):2717-22. PubMed ID: 15979652
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Antianxiety effects of lorazepam in patients with cardiovascular symptomatology.
    Finkel S
    J Clin Psychiatry; 1978 Oct; 39(10 Pt 2):35-40. PubMed ID: 30766
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Double blind, controlled study of the efficacy and safety of alpidem in the treatment of anxiety in schizophrenic in-patients.
    Minervini MG; Priore P; Farolfi A; Cesana B; Morselli PL
    Pharmacopsychiatry; 1990 Mar; 23(2):102-6. PubMed ID: 1971117
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Intensive design in evaluating anxiolytic agents.
    Uhlenhuth EH; Turner DA; Purchatzke G; Gift T; Chassan J
    Psychopharmacology (Berl); 1977 Mar; 52(1):79-85. PubMed ID: 15297
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Time-blind videotaped evaluation of injectable diazepam, lorazepam and placebo.
    Bobon DP; Fanielle J; Mormont C; Breulet M; Bobon J
    Acta Psychiatr Belg; 1978; 78(4):619-34. PubMed ID: 31063
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The role of captodiamine in the withdrawal from long-term benzodiazepine treatment.
    Mercier-Guyon C; Chabannes JP; Saviuc P
    Curr Med Res Opin; 2004 Sep; 20(9):1347-55. PubMed ID: 15383182
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A brief anxiety rating scale in evaluating anxiolytics.
    Wang RI; Wiesen RL; Treul S; Stockdale S
    J Clin Pharmacol; 1976; 16(2-3):99-105. PubMed ID: 3521
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A comparative study of suriclone, lorazepam and placebo in anxiety disorder.
    de Jonghe F; Swinkels J; Tuynman-Qua H; Jonkers F
    Pharmacopsychiatry; 1989 Nov; 22(6):266-71. PubMed ID: 2575766
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Controlled comparison of the efficacy and safety of four doses of suriclone, diazepam, and placebo in generalized anxiety disorder.
    Ansseau M; Olié JP; von Frenckell R; Jourdain G; Stehle B; Guillet P
    Psychopharmacology (Berl); 1991; 104(4):439-43. PubMed ID: 1685793
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Efficacy of venlafaxine extended-release capsules in nondepressed outpatients with generalized anxiety disorder: A 6-month randomized controlled trial.
    Gelenberg AJ; Lydiard RB; Rudolph RL; Aguiar L; Haskins JT; Salinas E
    JAMA; 2000 Jun; 283(23):3082-8. PubMed ID: 10865302
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A comparison of prazepam, diazepam, lorazepam and placebo in anxious outpatients in non-psychiatric private practices.
    Zung WW; Daniel JT; King RE; Moore DT
    J Clin Psychiatry; 1981 Jul; 42(7):280-4. PubMed ID: 6113234
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Single daily dose treatment of anxiety with clobazam or dipotassium clorazepate.
    Wallis TD; Vallé-Jones JC; Craven JR; Hanks GW; Stonier PD
    Br J Clin Pharmacol; 1979; 7 Suppl 1(Suppl 1):123S-127S. PubMed ID: 35192
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.